SERMO

What SERMO does

Sermo is a physician-first social engagement platform that connects over 1 million triple-verified physicians and healthcare professionals across 150+ countries. Founded in 2005 and headquartered in New York, the company operates a closed, credentialed community where physicians participate in peer discussions, post challenging patient cases (2M+ peer insights shared annually), rate drugs in the world's largest physician drug ratings database (1.2M+ ratings), and complete paid market research surveys (with over $25M distributed to medical professionals last year). The platform extends to dedicated sub-communities for Advanced Practice Providers and Pharmacists, and produces the recurring Sermo Barometer HCP sentiment study series, now in its 45th edition.

The underlying technology combines social networking infrastructure, a proprietary triple-verification credential system for physician onboarding, the Drug Ratings™ branded database, mobile applications (app.sermo.com), and AI-powered analytics for personalized marketing and engagement insights. The platform's core technical differentiator is its scale: 1.5M+ verified members producing a continuous stream of structured and unstructured clinical signal that competitors cannot easily replicate.

Sermo's business model is a two-sided platform play. Physicians access the network free of charge and earn supplemental income through paid surveys, while pharmaceutical companies, medical device firms, and biotech firms pay for access through multiple revenue streams including RealTime surveys, sponsored content, Sermo Conversations, Sermo Promo, and Sermo Ratings. The October 2025 launch of Engagement Manager added on-demand self-serve advertising, and the 2021 acquisition of Australia's Minter Group expanded Asia-Pacific reach with 50,000+ additional healthcare professionals. The company is privately held, has received approximately $101M in disclosed funding across multiple rounds (most recently Series 4 from ABRY Partners in 2019), and is led by CEO Peter Kirk.

Name

SERMO

Legal name

Sermo, Inc.

Website

https://sermo.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Healthcare Professional Network & Market Research Platform

NAICS

Web Search Portals, Libraries, Archives, and Other Information Services (519)

SIC

Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)

akta.pro secondary industry

Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)

Keywords

• Physician social network
• Healthcare market research
• HCP engagement platform
• Physician drug ratings
• Medical insights surveys

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Pharmaceutical and Healthcare Industry Insights: Sermo provides pharmaceutical companies, medical device firms, and biotech companies with access to physician expertise through sponsored content, engagement sponsorship, RealTime surveys, Sermo Conversations, Sermo Promo, and Sermo Ratings. Organizations underwrite market research and engagement sponsorship opportunities on the platform.
2. Market Research Surveys: Sermo facilitates paid medical surveys matching physician specialties, earning revenue from pharmaceutical clients who fund the surveys while physicians earn money for their participation. Medical professionals on Sermo earned over $25+ million in compensation last year.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

SERMO operates a verified physician-only social networking platform with over 1.5 million healthcare professionals across 150+ countries, providing peer-to-peer medical collaboration, paid medical surveys, and the world's largest physician drug ratings database (1.2M+ ratings). The company monetizes this network by offering pharmaceutical companies, medical device firms, and biotech clients access to physician insights, sponsored engagement, real-time market research surveys, and on-demand advertising via its Engagement Manager platform.

Product overview

Sermo is a physician-first social engagement platform and healthcare insights company offering a suite of interconnected products: the core Sermo Physician Social Network (a triple-verified social platform for 1M+ doctors), paired with the world's largest Drug Ratings Database (1.2M+ ratings) and a Paid Medical Survey program. The platform facilitates Peer Insights for case consultations (2M+ insights annually) and powers the Sermo Barometer, a recurring HCP sentiment study series now in its 45th edition that generates industry-wide healthcare insights. Additional offerings include the Engagement Manager (on-demand advertising access to verified HCPs), dedicated communities for APPs and Pharmacists, and a mobile application. The platform architecture combines social networking, market research, and real-world evidence generation for pharmaceutical and healthcare industry clients.

Differentiator

Problem solved

Functional benefit

Products and services

• Sermo Physician Social Network The primary social networking platform for verified physicians and healthcare professionals, enabling peer-to-peer medical discussions, case consultations, anonymous interactions, and professional networking across 1.5M+ members in 150+ countries.
• Drug Ratings Database The world's largest database of physician drug reviews containing over 1.2 million ratings, enabling physicians to share and access treatment reviews to improve patient care decisions globally.
• Paid Medical Surveys Market research surveys matching physician specialties that enable medical professionals to earn supplemental income by sharing clinical expertise through paid participation in healthcare research studies funded by pharma clients.
• Sermo Barometer A recurring HCP sentiment study series (45th edition) surveying thousands of global healthcare professionals on clinical trends, treatment patterns, industry challenges, and emerging therapies to generate actionable healthcare insights for pharmaceutical and industry clients.
• Engagement Manager An on-demand advertising platform enabling pharmaceutical companies and healthcare advertisers to access and target SERMO's community of 1M+ triple-verified healthcare professionals with sponsored content and advertising.

Quantifiable outcome

• 83% increase in global unique logins during COVID-19 pandemic
• +2 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Minter GroupcoreStrategic or Co-development Partner · 15 June 2021Acquired Australia-based market research leader Minter Group on June 15, 2021. The acquisition expanded Sermo's research panel to include over 50,000 Asia-Pacific healthcare professionals, strengthening connections between the pharmaceutical industry and healthcare providers in emerging markets, particularly Asia-Pacific.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Veeva Systems: Veeva Systems provides cloud-based software for life sciences companies, including CRM, data, and commercial engagement tools used by pharma sales and marketing teams. It overlaps with Sermo's pharma customer base and HCP engagement use cases, but as a broader enterprise platform rather than a physician community.
• Definitive Healthcare: Definitive Healthcare provides commercial intelligence and analytics on healthcare providers, including physicians, for life sciences and healthcare organizations. It is broadly comparable to Sermo as a healthcare commercial intelligence/data provider serving pharma clients.
• Indegene: Indegene provides commercialization services to life sciences companies, including medical affairs, marketing, and digital HCP engagement. It is comparable to Sermo in serving pharma clients with HCP-focused commercial engagement offerings, though broader and services-led.
• Kyruus: Kyruus operates a provider search, scheduling, and data management platform for health systems and life sciences. While it is a broader healthcare data and engagement player, its physician data and provider engagement capabilities overlap with Sermo's HCP intelligence offering.

Direct peers

• QuantiaMD: QuantiaMD was a physician-only social platform offering case collaboration, expert-led education, and peer discussions. It overlaps directly with Sermo's core verified-physician community and case consultation use cases as a focused HCP social platform.
• Doximity: Doximity is the largest professional medical network in the U.S. with over 2 million verified healthcare professional members. It is directly comparable to Sermo as a verified-HCP social networking platform serving physicians with networking, news, and pharma-sponsored content offerings.
• Healthcasts: Healthcasts provides physician engagement and education through peer-to-peer video and digital content platforms. It is comparable to Sermo as a digital HCP engagement platform serving pharmaceutical clients with educational and promotional content distribution to verified physicians.
• Medscape: Medscape (owned by WebMD) is a leading online destination for physicians and healthcare professionals offering clinical news, CME, and professional resources. It is directly comparable to Sermo's physician community and CME/education offerings, although Sermo adds a paid survey and engagement layer.

Emerging players

• Figure 1: Figure 1 is a medical case-sharing platform used by physicians to share de-identified clinical images and discuss patient cases. It overlaps with Sermo's peer insights and case consultation feature set, though focused on visual case sharing rather than broader HCP community engagement.
• ZoomRx: ZoomRx is a healthcare market research platform connecting pharma clients to physicians for surveys, advisory boards, and real-world insights. It is directly comparable to Sermo's paid survey and HCP market research offerings, though smaller and more focused on the U.S. market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/sermo
• Facebookfacebook.com/Sermo
• LinkedInlinkedin.com/company/773747

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds7 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SERMO